GONG SWOT ANALYSIS TEMPLATE RESEARCH B_116 Investors and consumers increasingly prioritize

Investors and consumers increasingly prioritize sustainability

FibroGen's R&D expenses were $117

0bn European SRAD wins (2025)

Field use: route-aware next-best-action in-car

particularly for late-stage clinical trials

GONG SWOT ANALYSIS TEMPLATE RESEARCH B_116 Investors and consumers increasingly prioritizeMake Insightful Decisions Backed by Expert Research Gong's AI driven revenue intelligence gives it clear strengths in sales analytics and market momentum, but competitive pressures and data privacy risks warrant close attention; purchase the full SWOT analysis to access a research backed, editable report with financial context, strategic takeaways, and an Excel matrix to support investment or strategic decisions. Strengths 40 percent market share in